Effectiveness and safety of dapagliflozin in real-life patients: data from the DAPA-RWE Spanish multicentre study

BACKGROUND: This study aims to evaluate dapagliflozin in patients with type 2 diabetes (T2D) in clinical practice in Spain. METHODS: This is a retrospective study including adults with T2D under stable antidiabetic therapy, with either dapagliflozin or sitagliptin ≥6 months, before inclusion. Data a...

Descripción completa

Detalles Bibliográficos
Autores principales: Morales, Cristóbal, Merino-Torres, Juan Francisco, Moreno-Moreno, Paloma, Lainez, María, Tejado, Iñigo, Yoldi, Alfredo, Gutiérrez Medina, Sonsoles, Soto, Alfonso, Botana, Manuel A, Bellido, Virginia, Caballero, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855933/
https://www.ncbi.nlm.nih.gov/pubmed/35251200
http://dx.doi.org/10.7573/dic.2021-11-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855933/
https://www.ncbi.nlm.nih.gov/pubmed/35251200
http://dx.doi.org/10.7573/dic.2021-11-5

Ejemplares similares